Rare disease research funding is limited but creative. Discover government grants, patient-led support, international alliances, networks, and emerging models driving progress for 7,000+ conditions.
Here we report on recent rare disease research in a clear, accurate, and balanced way, explaining what new studies actually show and what they do not. Articles cover laboratory discoveries, clinical studies, gene research, new therapies, and emerging technologies, as well as negative or inconclusive results that are rarely discussed in headlines.
Where possible, we explain the strength of the evidence, the size of the study, and how close the research is to real-world treatment.
The aim is to help readers stay informed about genuine progress without exaggeration, misunderstanding, or false hope.